The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer

SIGLEC9 plays a crucial role in the progression and prognosis of cervical cancer through its interaction with TAMs and T-cells. These findings highlight SIGLEC9 as a potential target for new immunotherapies in CC.

Institutions

Publication Details

Journal
Clinics
Published
2025-12-18
DOI
https://doi.org/10.1016/j.clinsp.2025.100849
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer

Clinics
Ubiquitin and proteasome pathways
article

The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer

article en

Abstract

SIGLEC9 plays a crucial role in the progression and prognosis of cervical cancer through its interaction with TAMs and T-cells. These findings highlight SIGLEC9 as a potential target for new immunotherapies in CC.

ClinicsVol. 81
Xinjiang Medical University (CN), First Affiliated Hospital of Xinjiang Medical University (CN), First Affiliated Hospital of Xi'an Jiaotong University (CN), First Hospital of Xi'an (CN), Southeast University (CN)
Openalex Percentile: Top 62%
Ubiquitin and proteasome pathways
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.